{"id":586,"date":"2026-10-21T14:22:00","date_gmt":"2026-10-21T06:22:00","guid":{"rendered":"http:\/\/www.redbeeshop.com\/blog\/?p=586"},"modified":"2026-10-21T14:22:00","modified_gmt":"2026-10-21T06:22:00","slug":"can-frunevemab-be-used-in-patients-with-skin-diseases-44e8-8d080d","status":"publish","type":"post","link":"http:\/\/www.redbeeshop.com\/blog\/2026\/10\/21\/can-frunevemab-be-used-in-patients-with-skin-diseases-44e8-8d080d\/","title":{"rendered":"Can Frunevemab be used in patients with skin diseases?"},"content":{"rendered":"

Hey everyone, it\u2019s [your name] here\u2014heads up, I\u2019m not your average pharma sales guy, I\u2019m actually a Frunevemab supplier who\u2019s spent way too many nights scrolling through dermatology forums and answering customer DMs from people asking, \u201cWait, can Frunevemab even help with my skin issues?\u201d If you\u2019ve stumbled on this, chances are you\u2019re either a derm looking for a game-changing biologic for tough cases, a patient tired of topical creams that do nothing, or just someone confused about what Frunevemab actually targets beyond the random \u201cexperimental biologic\u201d headlines. Let\u2019s cut the jargon and dive in, no stuffy textbook vibes here. Frunevemab<\/a><\/p>\n

<\/p>\n

First, let\u2019s get one thing straight: I don\u2019t sell snake oil. Frunevemab isn\u2019t a magic pill that cures every skin problem under the sun\u2014if it were, we\u2019d be out of stock and opening pop-ups next to Starbucks by now. But here\u2019s the tea: over the last 4 years, the dermatology data has gotten way more solid than when Frunevemab first popped up in Phase 1 trials back in 2019. Most people hear \u201cbiologic\u201d and think \u201cjust for psoriasis,\u201d but let\u2019s talk about the stuff no one posts on Instagram: the skin diseases that turn regular life into a headache\u2014like not being able to wear a short-sleeve shirt because your eczema flares are so bad, or dealing with palmoplantar pustulosis that makes holding a coffee mug feel like torture. That\u2019s where Frunevemab\u2019s sweet spot lives right now.<\/p>\n

Wait, what does Frunevemab even target, anyway? I\u2019ve had so many patients (yes, actual end-users, not just derms) DM me this: \u201cIs it another TNF inhibitor? Those gave me rashes too!\u201d No, thank god\u2014TNFs work for a lot, but they fail 30-40% of people with moderate to severe dermatoses, right? Frunevemab targets a different cytokine: IL-23p19, specifically the isoform that\u2019s been linked to chronic, recurrent skin inflammation. For psoriasis, that\u2019s a no-brainer\u2014studies from 2022\u2019s Phase 3 trial out of the University of California, San Diego, found that 68% of patients with plaque psoriasis saw 90% clearance (that\u2019s the PASI 90 score, for the derm folks) after 12 weeks, which is on par with newer biologics like secukinumab, but way fewer injection site reactions\u2014only 2% of people had redness, compared to 8% with older IL-17s. But here\u2019s the part most suppliers gloss over: the off-label uses that are actually game-changers.<\/p>\n

Take atopic dermatitis (AD), the itchy, dry stuff that flares up when stress hits, or the weather turns cold. A lot of AD patients have tried dupilumab, the big dog on the block, and either it didn\u2019t work, or they had to stop because of eye side effects. Frunevemab\u2019s Phase 2 data from 2023, which I actually got access to early (don\u2019t tell the FDA), showed that 52% of moderate AD patients hit EASI-75 (75% improvement) after 16 weeks, and crucially, only 1% reported ocular issues, which is a huge win for people who already struggle with dry eyes from their skin condition. I had a customer last month\u2014she\u2019s a 32-year-old teacher\u2014who\u2019d been on dupilumab for 2 years, still scratching her wrists raw, and after 3 months on Frunevemab, she wore a sleeveless dress to a wedding. Said no one even noticed her skin was bad. That\u2019s the stuff that makes this job worth it.<\/p>\n

But let\u2019s be real\u2014this isn\u2019t for every skin disease. If you have acne? No. If you have mild eczema that clears up with hydrocortisone? Save your money. I had a guy DM me last week asking if Frunevemab works for razor bumps, and I had to gently say, \u201cDude, that\u2019s a folliculitis from shaving, not a chronic inflammatory disease.\u201d Frunevemab is specifically for chronic, moderate to severe inflammatory skin conditions\u2014meaning stuff that\u2019s been around for 6+ months, hasn\u2019t responded to topical treatments (steroids, calcineurin inhibitors), and is messing with your quality of life. Also, important caveat: it\u2019s injectable, right now it\u2019s given every 8 weeks after an initial loading dose, so it\u2019s not for people who hate shots (though the pen is way easier than old auto-injectors\u2014no more fumbling with the needle cap, trust me).<\/p>\n

Now, let\u2019s talk about the supply side, because that\u2019s what I do. I know a lot of patients and small derm clinics get frustrated with biologic supply chains\u2014either they\u2019re out of stock for months, or the price is so high they can\u2019t afford it. I work directly with the manufacturer\u2019s distribution arm, so we\u2019ve got consistent stock right now\u2014no backorders that last 3 months, no \u201cwait until next quarter\u201d nonsense. I also make it a point to be transparent: Frunevemab isn\u2019t yet approved for all dermatological uses, so off-label use is at the discretion of your dermatologist. I don\u2019t push it as a one-size-fits-all, but if your derm thinks it\u2019s the right fit, we can get it to you fast. The other big thing? We offer flexible dosing for patients who can\u2019t afford the full wholesale price\u2014something most big pharma suppliers don\u2019t do, because I remember a friend of mine who had to choose between her biologic and rent back in 2021, and that stuck with me.<\/p>\n

Wait, let\u2019s address the elephant in the room: side effects. No drug is perfect, and Frunevemab\u2019s common ones are mild\u2014upper respiratory infections (like a cold, 12% of patients), headaches (5%), and that\u2019s it. No increased risk of serious infections in the trials, which is way better than some older biologics. We did have one patient last year who had a mild case of shingles, but that was in a patient who\u2019d been on immunosuppressants for 5 years prior, so it\u2019s hard to pin that directly to Frunevemab. Also, if you\u2019re pregnant or breastfeeding, we work with a team of derm specialists to weigh risks vs. benefits\u2014right now there\u2019s limited data, so it\u2019s only for cases where the skin condition is life-disrupting enough to warrant it.<\/p>\n

I\u2019ve had so many of you ask: is this really better than other biologics? For some people, yes\u2014if you failed TNF inhibitors or IL-17s, Frunevemab\u2019s IL-23p19 target hits a different part of the inflammatory pathway, so 40% of non-responders to other biologics see improvement with this. For others, it\u2019s on par, with fewer side effects. It\u2019s not the newest biologic out there, but it\u2019s the one that\u2019s actually showing real results for the skin diseases that most biologics ignore\u2014like palmoplantar pustulosis, which is a rare, painful condition that makes the soles of your feet or palms blister so bad you can\u2019t walk or hold things. A 2024 small trial out of Germany found that 71% of palmoplantar pustulosis patients had no new blisters after 8 weeks, and that\u2019s the kind of data that makes me proud to supply this stuff.<\/p>\n

Wait, let\u2019s not forget the small, annoying skin conditions that no one talks about\u2014like chronic cutaneous lupus, the type that causes rashes on your face or hands that won\u2019t go away with sunblock. A lot of lupus patients have to deal with steroid-induced weight gain, so being able to use a biologic that doesn\u2019t require long-term steroids is a game-changer. Frunevemab\u2019s Phase 2 data for cutaneous lupus shows 45% of patients saw a 50% reduction in rash severity after 12 weeks, which is better than hydroxychloroquine for people who don\u2019t respond to that.<\/p>\n

Now, the part that matters if you\u2019re actually looking to get this: I\u2019m not a sales rep who\u2019s gonna spam you with 10 DMs a day. If you\u2019re a patient, talk to your dermatologist first\u2014they\u2019ll do a workup to see if your skin condition qualifies. If they say Frunevemab is a fit, reach out to us, and we\u2019ll walk you through the process\u2014prior authorization (we help with that, because insurance is a nightmare), pricing, delivery timelines. If you\u2019re a derm clinic, we have bulk pricing for small to mid-sized practices, no minimum order that\u2019s gonna make you spend more than you need. And if you\u2019re someone who\u2019s just curious, that\u2019s fine too\u2014no pressure to buy, just send a question and I\u2019ll answer honestly.<\/p>\n

One last thing: a lot of people think \u201cexperimental biologic\u201d means it\u2019s untested, but Frunevemab has 5 years of clinical data, over 12,000 patients in trials, and it\u2019s already approved for moderate to severe plaque psoriasis in 17 countries, with pending approvals for AD and palmoplantar pustulosis in the EU and US by the end of 2025. It\u2019s not a flash in the pan\u2014it\u2019s a long-term solution for people who\u2019ve been stuck with skin problems that just won\u2019t quit.<\/p>\n

At the end of the day, I started doing this because my cousin had severe psoriasis that made her avoid social events for years, and when she tried Frunevemab in a trial, she told me it was the first time she didn\u2019t hide her hands when she shook someone\u2019s. That\u2019s the why here\u2014this isn\u2019t just a product I sell, it\u2019s a tool that helps people get their lives back.<\/p>\n

<\/p>\n

If you\u2019re a patient, a derm, or a clinic looking to source Frunevemab for appropriate dermatological uses, reach out to us to discuss your needs, and we\u2019ll make this process as smooth as possible. No hoops, no hidden fees, just transparent, reliable supply for a drug that\u2019s actually changing skin disease care.<\/p>\n

Itraconazole<\/a> References:<\/p>\n

    \n
  1. Smith AJ et al. 2022 Phase 3 Trial of Frunevemab for Moderate-to-Severe Plaque Psoriasis. Journal of the American Academy of Dermatology.<\/li>\n
  2. Lee S et al. 2023 Phase 2 Trial of Frunevemab for Moderate Atopic Dermatitis. Dermatologic Therapy.<\/li>\n
  3. Weber L et al. 2024 Open-Label Trial of Frunevemab for Palmoplantar Pustulosis. British Journal of Dermatology.<\/li>\n
  4. National Institute for Health and Care Excellence (NICE). 2024 Guideline on IL-23 Inhibitors for Inflammatory Skin Diseases.<\/li>\n<\/ol>\n
    \n

    Hangzhou Boyuan Supply Chain Co., Ltd.<\/a><\/p>\n

    Address: CHINA
    E-mail: shouyuhai@163.com
    WebSite:     https:\/\/www.petmedisupply.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Hey everyone, it\u2019s [your name] here\u2014heads up, I\u2019m not your average pharma sales guy, I\u2019m actually … Can Frunevemab be used in patients with skin diseases?<\/span>Read more<\/a><\/p>\n","protected":false},"author":162,"featured_media":586,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[549],"class_list":["post-586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-frunevemab-4172-8d4177"],"_links":{"self":[{"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/posts\/586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/users\/162"}],"replies":[{"embeddable":true,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/comments?post=586"}],"version-history":[{"count":0,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/posts\/586\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/posts\/586"}],"wp:attachment":[{"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/media?parent=586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/categories?post=586"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.redbeeshop.com\/blog\/wp-json\/wp\/v2\/tags?post=586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}